Profit Margin (Quarterly) Chart

Historical Profit Margin (Quarterly) Data

View and export this data back to 2009. Start Trial.
Date Value
June 30, 2026 -535.2%
March 31, 2026 -21.84K%
December 31, 2025 -1.73M%
September 30, 2025 -2.16M%
June 30, 2025 -73.29K%
March 31, 2025 -2.07K%
December 31, 2024 -23.57K%
September 30, 2024 -54.61K%
June 30, 2024 -3.65K%
March 31, 2024 -72.74K%
December 31, 2023 -936.2%
September 30, 2023 -406.2%
June 30, 2023 -800.5%
March 31, 2023 -1.43K%
December 31, 2022 -2.18K%
September 30, 2022 -890.6%
June 30, 2022 -2.80K%
March 31, 2022 -1.07K%
December 31, 2021 -1.63K%
September 30, 2021 -1.73K%
June 30, 2021 -735.0%
March 31, 2021 -1.39K%
December 31, 2020 -3.90K%
September 30, 2020 -1.31K%
June 30, 2020 -1.96K%
Date Value
March 31, 2020 -1.54K%
December 31, 2019 -3.90K%
September 30, 2019 -766.9%
June 30, 2019
March 31, 2019 -1.29K%
December 31, 2018 -1.11K%
September 30, 2018 -759.9%
June 30, 2018 -661.9%
March 31, 2018 -427.6%
December 31, 2017 -1.30K%
September 30, 2017 -650.6%
June 30, 2017 -2.38K%
March 31, 2017 -765.9%
December 31, 2016 -524.9%
September 30, 2016 -784.2%
June 30, 2016 -3.00K%
March 31, 2016 -2.25K%
December 31, 2015 -1.23K%
September 30, 2015 -1.30K%
June 30, 2015 -506.5%
March 31, 2015 -149.2%
December 31, 2014 -1.43K%
September 30, 2014 -280.7%
June 30, 2014 -545.4%
March 31, 2014 -2.30K%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Enovis Corp. -0.18%
Edwards Lifesciences Corp. 13.87%
Intuitive Surgical, Inc. 28.46%
Kewaunee Scientific Corp. 2.78%
STAAR Surgical Co. 8.62%